Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

Wang C, Jiang K, Kang X, Gao D, Sun C, Li Y, Sun L, Zhang S, Liu X, Wu W, Yang P, Guo K, Liu Y.

Int J Biochem Cell Biol. 2012 Dec;44(12):2308-20. doi: 10.1016/j.biocel.2012.09.012. Epub 2012 Sep 23.

PMID:
23010347
2.

Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition process.

Yau WL, Lam CS, Ng L, Chow AK, Chan ST, Chan JY, Wo JY, Ng KT, Man K, Poon RT, Pang RW.

PLoS One. 2013;8(3):e57882. doi: 10.1371/journal.pone.0057882. Epub 2013 Mar 6.

3.

Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.

Niu Z, Li X, Hu B, Li R, Wang L, Wu L, Wang X.

Acta Biochim Biophys Sin (Shanghai). 2012 Dec;44(12):991-8. doi: 10.1093/abbs/gms091. Epub 2012 Oct 25.

PMID:
23099883
4.

Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.

Wang C, Guo K, Gao D, Kang X, Jiang K, Li Y, Sun L, Zhang S, Sun C, Liu X, Wu W, Yang P, Liu Y.

Cancer Lett. 2011 Dec 27;313(2):154-66. doi: 10.1016/j.canlet.2011.08.031. Epub 2011 Oct 8.

PMID:
22023829
5.

The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma.

Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R, Chen Y, Gao X, Zhu Q, Yue X, Pan Q, Xu S, Li J, Huang M, Daugherty-Holtrop J, He Y, Xu HE, Fan J, Ding J, Geng M.

J Natl Cancer Inst. 2011 Nov 16;103(22):1696-712. doi: 10.1093/jnci/djr360. Epub 2011 Oct 24.

6.

Antisense oligonucleotide against clusterin regulates human hepatocellular carcinoma invasion through transcriptional regulation of matrix metalloproteinase-2 and E-cadherin.

Chen D, Wang Y, Zhang K, Jiao X, Yan B, Liang J.

Int J Mol Sci. 2012;13(8):10594-607. doi: 10.3390/ijms130810594. Epub 2012 Aug 23.

7.

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J.

Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.

8.

Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP, Huang G.

FEBS J. 2012 Oct;279(20):3898-910. doi: 10.1111/j.1742-4658.2012.08748.x. Epub 2012 Sep 13.

9.

Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.

Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG.

Hepatology. 2013 Oct;58(4):1349-61. doi: 10.1002/hep.26467. Epub 2013 Aug 7.

PMID:
23696034
10.

Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.

Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F, Sun SH.

Carcinogenesis. 2013 Mar;34(3):577-86. doi: 10.1093/carcin/bgs381. Epub 2012 Dec 7.

PMID:
23222811
11.

SIN1 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition.

Xu J, Li X, Yang H, Chang R, Kong C, Yang L.

Cancer. 2013 Jun 15;119(12):2247-57. doi: 10.1002/cncr.28023. Epub 2013 Apr 5.

12.

Sorafenib down-regulates expression of HTATIP2 to promote invasiveness and metastasis of orthotopic hepatocellular carcinoma tumors in mice.

Zhang W, Sun HC, Wang WQ, Zhang QB, Zhuang PY, Xiong YQ, Zhu XD, Xu HX, Kong LQ, Wu WZ, Wang L, Song TQ, Li Q, Tang ZY.

Gastroenterology. 2012 Dec;143(6):1641-1649.e5. doi: 10.1053/j.gastro.2012.08.032. Epub 2012 Aug 23.

PMID:
22922424
13.

Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.

Xiu P, Dong X, Dong X, Xu Z, Zhu H, Liu F, Wei Z, Zhai B, Kanwar JR, Jiang H, Li J, Sun X.

Cancer Sci. 2013 Mar;104(3):375-82. doi: 10.1111/cas.12088. Epub 2013 Jan 30.

14.

Clusterin silencing inhibits proliferation and reduces invasion in human laryngeal squamous carcinoma cells.

Wang Q, Cao W, Su Q, Liu Z, Zhang L.

World J Surg Oncol. 2014 Apr 26;12:124. doi: 10.1186/1477-7819-12-124.

15.

Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.

Tai CJ, Chin-Sheng H, Kuo LJ, Wei PL, Lu HH, Chen HA, Liu TZ, Liu JJ, Liu DZ, Ho YS, Wu CH, Chang YJ.

Ann Surg Oncol. 2012 Jan;19(1):336-43. doi: 10.1245/s10434-011-1692-5. Epub 2011 Apr 23.

PMID:
21516372
16.

MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition.

Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang X, Liu Q, Zhang J.

Liver Int. 2013 Sep;33(8):1271-80. doi: 10.1111/liv.12190. Epub 2013 Jun 3.

PMID:
23725476
17.

Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma.

Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu X, Sun J, Yang S, Poon RT, Fan ST.

Int J Cancer. 2012 Aug 1;131(3):E163-72. doi: 10.1002/ijc.27336. Epub 2011 Dec 14.

18.

[Effects of high metastatic potential hepatocellular carcinoma cell-binding peptide on the invasion and metastasis of liver cancer].

Jia WD, Wang W, Tang ZY, Xu GL, Sun HC, Zhou HJ.

Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):241-5. Chinese.

PMID:
19615273
19.
20.

Reconstitution of secreted frizzled-related protein 1 suppresses tumor growth and lung metastasis in an orthotopic model of hepatocellular carcinoma.

Jiang GX, Liu W, Cui YF, Zhong XY, Tai S, Wang ZD, Shi YG, Li CL, Zhao SY.

Dig Dis Sci. 2010 Oct;55(10):2838-43. doi: 10.1007/s10620-009-1099-3. Epub 2009 Dec 24.

PMID:
20033841

Supplemental Content

Support Center